Pravastatin, Simvastatin, and Lovastatin For Serum Cholesterol Concentrations
Pravastatin - Bristol-Myers Squibb) and simvastatin (Zocor -Merck), two new inhibitors of cholesterol synthesis similar to lovastatin (Mevacor - Merck), have now been marketed in the USA for treatment of hypercholesterolemia. Lovastatin (Medical Letter, 29:99, 1987) is the most frequently prescribed of all cholesterol-lowering drugs in the USA. Pravastatin and simvastatin were previously reviewed in The Medical Letter when they became available in Canada (volume 33, page 18, 1991)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Pravastatin, Simvastatin, and Lovastatin For Serum Cholesterol Concentrations
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 872
Article Code: 872a
Date: June 12, 1992
Volume: 34
Pages: 57-58
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 872
Article Code: 872a
Date: June 12, 1992
Volume: 34
Pages: 57-58
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)